{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:09:12Z","timestamp":1791806952130,"version":"4.3.4"},"reference-count":103,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["16-27449A"],"award-info":[{"award-number":["16-27449A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Ulcerative colitis (UC) is an inflammatory bowel disease, and intestinal bacteria are implicated in the pathogenesis of this disorder. The administration of aminosalicylates (5-ASA) is a conventional treatment that targets the mucosa, while fecal microbial transplantation (FMT) is a novel treatment that directly targets the gut microbiota. The aim of this study was to identify changes in fecal bacterial composition after both types of treatments and evaluate clinical responses. Sixteen patients with active left-sided UC underwent enema treatment using 5-ASA (n = 8) or FMT (n = 8) with a stool from a single donor. Fecal microbiota were analyzed by 16S rDNA high-throughput sequencing, and clinical indices were used to assess the efficacy of treatments. 5-ASA therapy resulted in clinical remission in 50% (4\/8) of patients, but no correlation with changes in fecal bacteria was observed. In FMT, remission was achieved in 37.5% (3\/8) of patients and was associated with a significantly increased relative abundance of the families Lachnospiraceae, Ruminococcaceae, and Clostridiaceae of the phylum Firmicutes, and Bifidobacteriaceae and Coriobacteriaceae of the phylum Actinobacteria. At the genus level, Faecalibacterium, Blautia, Coriobacteria, Collinsela, Slackia, and Bifidobacterium were significantly more frequent in patients who reached clinical remission. However, the increased abundance of beneficial taxa was not a sufficient factor to achieve clinical improvement in all UC patients. Nevertheless, our preliminary results indicate that FMT as non-drug-using method is thought to be a promising treatment for UC patients.<\/jats:p>","DOI":"10.3390\/cells9102283","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T21:42:21Z","timestamp":1602798141000},"page":"2283","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9906-9072","authenticated-orcid":false,"given":"Dagmar","family":"Schierov\u00e1","sequence":"first","affiliation":[{"name":"Institute of Animal Physiology and Genetics of the Czech Academy of Science, v.v.i., 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"B\u0159ezina","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-3333","authenticated-orcid":false,"given":"Jakub","family":"Mr\u00e1zek","sequence":"additional","affiliation":[{"name":"Institute of Animal Physiology and Genetics of the Czech Academy of Science, v.v.i., 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-8168","authenticated-orcid":false,"given":"Kate\u0159ina Ol\u0161a","family":"Fliegerov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Animal Physiology and Genetics of the Czech Academy of Science, v.v.i., 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-7795","authenticated-orcid":false,"given":"Simona","family":"Kvasnov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Animal Physiology and Genetics of the Czech Academy of Science, v.v.i., 142 20 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3815-3120","authenticated-orcid":false,"given":"Luk\u00e1\u0161","family":"Bajer","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Drastich","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Siew","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.53.1.1","article-title":"Dysbiosis in inflammatory bowel disease","volume":"53","author":"Tamboli","year":"2004","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1365-2036.2011.04619.x","article-title":"Review article: Delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis","volume":"33","author":"Harris","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_4","first-page":"1","article-title":"5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15227","article-title":"Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis","volume":"49","author":"Olaisen","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ismej.2017.44","article-title":"Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation","volume":"11","author":"Fuentes","year":"2017","journal-title":"ISME J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41591-018-0308-z","article-title":"Microbial network disturbances in relapsing refractory Crohn\u2019s disease","volume":"25","author":"Yilmaz","year":"2019","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/cid\/cir632","article-title":"Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent clostridium difficile infection","volume":"53","author":"Gough","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10096-014-2088-9","article-title":"The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema","volume":"33","author":"Lee","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shi, Y., Dong, Y., Huang, W., Zhu, D., Mao, H., and Su, P. (2016). Fecal microbiota transplantation for ulcerative colitis: A systematic review and meta-analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157259"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients with Ulcerative Colitis: A Randomized Clinical Trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MIB.0000000000001132","article-title":"Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis","volume":"23","author":"Jacob","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, H., Huang, H., Xu, H., Luo, Q., He, J., Li, Y., Zhou, Y., Nie, Y., and Zhou, Y. (2020). Fecal microbiota transplantation ameliorates active ulcerative colitis. Exp. Ther. Med., 2650\u20132660.","DOI":"10.3892\/etm.2020.8512"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cui, B., Li, P., Xu, L., Zhao, Y., Wang, H., Peng, Z., Xu, H., Xiang, J., He, Z., and Zhang, T. (2015). Step-up fecal microbiota transplantation strategy: A pilot study for steroid-dependent ulcerative colitis. J. Transl. Med., 13.","DOI":"10.1186\/s12967-015-0646-2"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1097\/MIB.0b013e31829ea325","article-title":"Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis","volume":"19","author":"Kump","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Damman, C.J., Brittnacher, M.J., Westerhoff, M., Hayden, H.S., Radey, M., Hager, K.R., Marquis, S.R., Miller, S.I., and Zisman, T.L. (2015). Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133925"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Venegas, D.P., De La Fuente, M.K., Landskron, G., Gonz\u00e1lez, M.J., Quera, R., Dijkstra, G., Harmsen, H.J.M., Faber, K.N., and Hermoso, M.A. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01486"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajg.2013.257","article-title":"Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation","volume":"108","author":"Angelberger","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lee, J.G., Han, D.S., Jo, S.V., Reum Lee, A., Park, C.H., Eun, C.S., and Lee, Y. (2019). Characteristics and pathogenic role of adherent-invasive Escherichia coli in inflammatory bowel disease: Potential impact on clinical outcomes. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216165"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Borody, T., George, L., Andrews, P., Brandl, S., Noonan, S., Cole, P., Hyland, L., Mrogan, A., Maysey, J., and Moore-Jones, D. (1989). Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome?. Med. J. Aust., 150.","DOI":"10.5694\/j.1326-5377.1989.tb136704.x"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2144\/04365ST04","article-title":"Improved extraction of PCR-quality community DNA from digesta and fecal samples","volume":"36","author":"Yu","year":"2004","journal-title":"BioTechniques"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anaerobe.2013.09.015","article-title":"Effect of DNA extraction and sample preservation method on rumen bacterial population","volume":"29","author":"Fliegerova","year":"2014","journal-title":"Anaerobe"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rognes, T., Flouri, T., Nichols, B., Quince, C., and Mah\u00e9, F. (2016). VSEARCH: A versatile open source tool for metagenomics. PeerJ, 4.","DOI":"10.7717\/peerj.2584"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2047-217X-2-16","article-title":"EMPeror: A tool for visualizing high-throughput microbial community data","volume":"2","author":"Pirrung","year":"2013","journal-title":"GigaScience"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2174\/138945011796818126","article-title":"Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?","volume":"12","author":"Cottone","year":"2011","journal-title":"Current Drug Targets"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wang, Y., Parker, C., Feagan, B., and MacDonald, J. (2016). Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.pdf. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD000544.pub4"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Safdi, M., DeMicco, M., Sninsky, C., Banks, P., Wruble, L., Deren, J., Koval, G., Nicols, T., Targan, S., and Taylor, D. (1995). A double-blind comparison of oral versus rectal mesalazine versus combinational therapy in the treatment of distal ulcerative colitis. Immunol. Microbiol. Inflammat. Dis., 108.","DOI":"10.1016\/0016-5085(95)27940-7"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(02)01383-9","article-title":"Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis","volume":"114","author":"Kane","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2036.2011.04732.x","article-title":"Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome","volume":"34","author":"Andrews","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature14139","article-title":"Vertically transmitted fecal IgA levels distinguish extra-chromosomal phenotypic variation","volume":"521","author":"Moon","year":"2015","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tim.2020.02.018","article-title":"Sutterella Species, IgA-degrading Bacteria in Ulcerative Colitis","volume":"28","author":"Kaakoush","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/apt.14387","article-title":"The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis","volume":"47","author":"Kump","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/MIB.0000000000001228","article-title":"Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis","volume":"23","author":"Narula","year":"2017","journal-title":"Inflammat. Bowel Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cao, Y., Zhang, B., Wu, Y., Wang, Q., Wang, J., and Shen, F. (2018). The value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: A systematic review and meta-analysis. Gastroenterol. Res. Pr., 2018.","DOI":"10.1155\/2018\/5480961"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Tian, Y., Zhou, Y., Huang, S., Li, J., Zhao, K., Li, X., Wen, X., and Li, X.A. (2019). Fecal microbiota transplantation for ulcerative colitis: A prospective clinical study. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-019-1010-4"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.02120-17","article-title":"Fecal microbiota signatures are associated with response to ustekinumab therapy among crohn\u2019s disease patients","volume":"9","author":"Doherty","year":"2018","journal-title":"mBio"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5534\/wjmh.190009","article-title":"Sex Differences in Gut Microbiota","volume":"38","author":"Kim","year":"2020","journal-title":"World J. Mens Health"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Dominianni, C., Sinha, R., Goedert, J.J., Pei, Z., Yang, L., Hayes, R.B., and Ahn, J. (2015). Sex, Body Mass Index, and Dietary Fiber Intake Influence The Human Gut Microbiome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124599"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature13178","article-title":"Dynamics and associations of microbial community types across the human body","volume":"509","author":"Ding","year":"2014","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Fransen, F., van Beek, A.A., Borghuis, T., Meijer, B., Hugenholtz, F., Jongh, C.V.D.G.-D., Savelkoul, H.F., de Jonge, M.I., Faas, M.M., and Boekschoten, M.V. (2017). The impact of gut microbiota on gender-specific differences in immunity. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00754"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00002","article-title":"The super-donor phenomenon in fecal microbiota transplantation","volume":"9","author":"Wilson","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Odamaki, T., Kato, K., Sugahara, H., Hashikura, N., Takahashi, S., Xiao, J.Z., Abe, F., and Osawa, R. (2016). Age-related changes in gut microbiota composition from newborn to centenarian: A cross-sectional study. BMC Microbiol., 16.","DOI":"10.1186\/s12866-016-0708-5"},{"key":"ref_49","unstructured":"Vos, P., Garrity, G., Jones, D., Krieg, N.R., Ludwig, W., Rainey, F.A., Schleifer, K.-H., and Whitman, W. (2009). Bergey\u2019s Manual of Systematic Bacteriology, Springer."},{"key":"ref_50","first-page":"13780","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Vacca, M., Celano, G., Calabrese, F.M., Portincasa, P., Gobbetti, M., and Angelis, M. (2020). De The controversial role of human gut lachnospiraceae. Microorganisms, 8.","DOI":"10.3390\/microorganisms8040573"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Vital, M., Karch, A., and Pieper, D.H. (2017). Colonic Butyrate-Producing Communities in Humans: An Overview Using Omics Data. mSystems, 2.","DOI":"10.1128\/mSystems.00130-17"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/AEM.69.7.4320-4324.2003","article-title":"Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces","volume":"69","author":"Hold","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.3748\/wjg.v23.i25.4624","article-title":"Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities","volume":"23","author":"Chen","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2012.06553.x","article-title":"Microbial butyrate and its role for barrier function in the gastrointestinal tract","volume":"1258","author":"Stumpff","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Laursen, M.F., Laursen, R.P., Larnkj\u00e6r, A., M\u00f8lgaard, C., Michaelsen, K.F., Fr\u00f8ki\u00e6r, H., Bahl, M.I., and Licht, T.R. (2017). Faecalibacterium Gut Colonization Is Accelerated by Presence of Older Siblings. mSphere, 2.","DOI":"10.1128\/mSphere.00448-17"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00365521.2019.1599417","article-title":"Alterations in the relative abundance of Faecalibacterium prausnitzii correlate with changes in fecal calprotectin in patients with ileal Crohn\u2019s disease: A longitudinal study","volume":"54","author":"Repsilber","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan, A., and Sinderen, D. (2016). van Bifidobacteria and their role as members of the human gut microbiota. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00925"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2036.1999.00560.x","article-title":"Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis","volume":"13","author":"Venturi","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13099-019-0341-6","article-title":"Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels","volume":"12","author":"Alam","year":"2020","journal-title":"Gut Pathogens"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","article-title":"Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD","volume":"66","author":"Lee","year":"2017","journal-title":"Gut"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fmicb.2016.00658","article-title":"Quantification of Slackia and Eggerthella spp. In human feces and adhesion of representatives strains to Caco-2 cells","volume":"7","author":"Cho","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1093\/jn\/132.12.3577","article-title":"The Clinical Importance of the Metabolite Equol\u2014A Clue to the Effectiveness of Soy and Its Isoflavones","volume":"132","author":"Setchell","year":"2002","journal-title":"J. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sj\u00f6berg, F., Barkman, C., Nookaew, I., \u00d6stman, S., Adlerberth, I., Saalman, R., and Wold, A.E. (2017). Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186178"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13059-019-1879-9","article-title":"Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host","volume":"20","author":"Seishima","year":"2019","journal-title":"Genome Biology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects","volume":"133","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"The Interplay of Host Genetics and the Gut Microbiota Underlying the Onset and Clinical Presentation of Inflammatory Bowel Disease","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"key":"ref_69","first-page":"1","article-title":"Composition, Diversity and Abundance of Gut Microbiome in Prediabetes and Type 2 Diabetes","volume":"2","author":"Lambeth","year":"2015","journal-title":"J. Diabetes Obes."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2017.1406584","article-title":"Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women","volume":"9","author":"Barrett","year":"2018","journal-title":"Gut Microbes"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","article-title":"An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis","volume":"8","author":"Chen","year":"2016","journal-title":"Genome Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Waters, J.L., and Ley, R.E. (2019). The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol., 17.","DOI":"10.1186\/s12915-019-0699-4"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.cub.2016.04.016","article-title":"Gut Microbiota and Extreme Longevity","volume":"26","author":"Biagi","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1462-2920.2012.02845.x","article-title":"Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure","volume":"15","author":"Ferrer","year":"2013","journal-title":"Environ. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human genetics shape the gut microbiome. PubMed Commons","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Alem\u00e1n, J.O., Bokulich, N.A., Swann, J.R., Walker, J.M., Rosa, J.C., Battaglia, T., Costabile, A., Pechlivanis, A., Liang, Y., and Breslow, J.L. (2018). Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women. J. Transl. Med., 16.","DOI":"10.1186\/s12967-018-1619-z"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1097\/MIB.0000000000000549","article-title":"Metagenomic analysis of Crohn\u2019s disease patients identifies changes in the virome and microbiome related to disease status and therapy, and detects potential interactions and biomarkers","volume":"21","author":"Nos","year":"2015","journal-title":"Inflammatory Bowel Diseases"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","article-title":"A microbial signature for Crohn\u2019s disease","volume":"66","author":"Pascal","year":"2017","journal-title":"Gut"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ecco-jcc\/jjw136","article-title":"Microbial Factors Associated with Postoperative Crohn\u2019s Disease Recurrence","volume":"11","author":"Wright","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Papa, E., Docktor, M., Smillie, C., Weber, S., Preheim, S.P., Gevers, D., Giannoukos, G., Ciulla, D., Tabbaa, D., and Ingram, J. (2012). Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039242"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MIB.0b013e31827fec6d","article-title":"De Phylogenetic analysis of dysbiosis in ulcerative colitis during remission","volume":"19","author":"Shanahan","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsec\/fix153","article-title":"Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis","volume":"93","author":"Mancabelli","year":"2017","journal-title":"FEMS Microbiol. Ecol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jfda.2018.12.011","article-title":"Next generation probiotics in disease amelioration","volume":"27","author":"Chang","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tim.2016.02.015","article-title":"Oscillospira: A Central, Enigmatic Component of the Human Gut Microbiota","volume":"24","author":"Konikoff","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/1462-2920.13658","article-title":"Oscillospira and related bacteria\u2013from metagenomics species to metabolic features","volume":"19","author":"Gophna","year":"2017","journal-title":"Environ. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.febslet.2014.09.039","article-title":"Meta-analyses of human gut microbes associated with obesity and IBD","volume":"588","author":"Walters","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","article-title":"Intestinal Lactobacillus in health and disease, a driver or just along for the ride?","volume":"49","author":"Heeney","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.dld.2017.01.142","article-title":"Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis","volume":"49","author":"Liu","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jgh.13471","article-title":"Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis","volume":"32","author":"Zhuang","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/JCM.01500-13","article-title":"Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease","volume":"52","author":"Wang","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2036.2011.04939.x","article-title":"Randomised clinical trial: The effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis","volume":"35","author":"Oliva","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ajg.2014.202","article-title":"Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jcp.25911","article-title":"Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review","volume":"233","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4056\/sigs.1714269","article-title":"Complete genome sequence of odoribacter splanchnicus type strain (1651\/6 T)","volume":"4","author":"Gronow","year":"2011","journal-title":"Stand. Genom. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., A Reyes, J., A Shah, S., Leleiko, N., and Snapper, S.B. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol., 13.","DOI":"10.1186\/gb-2012-13-9-r79"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2015.09.008","article-title":"Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn\u2019s Disease","volume":"18","author":"Lewis","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ecco-jcc\/jjx153","article-title":"Characteristics of faecal microbiota in paediatric Crohn\u2019s disease and their dynamic changes during infliximab therapy","volume":"12","author":"Wang","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1099\/ijs.0.008169-0","article-title":"Paraprevotella clara gen. nov., sp. nov. and Paraprevotella xylaniphila sp. nov., members of the family \u201cPrevotellaceae\u201d isolated from human faeces","volume":"59","author":"Morotomi","year":"2009","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Connors, J., Dawe, N., and Limbergen, J. (2019). Van The role of succinate in the regulation of intestinal inflammation. Nutrients, 11.","DOI":"10.3390\/nu11010025"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00011-011-0340-7","article-title":"GC\/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis","volume":"60","author":"Ooi","year":"2011","journal-title":"Inflam. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11154-019-09513-z","article-title":"Gut microbiota-derived succinate: Friend or foe in human metabolic diseases?","volume":"20","author":"Vendrell","year":"2019","journal-title":"Rev. Endocr. Metab. Dis."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:20:36Z","timestamp":1760178036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":103,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["cells9102283"],"URL":"https:\/\/doi.org\/10.3390\/cells9102283","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}